Consolidation Therapy in Patients With Hematologic Malignancies

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 28, 2017

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
CancerHematologic Malignancies
Interventions
BIOLOGICAL

TAPA-pulsed DC vaccine

A cycle of low-dose cyclophosphamide (100mg/day) by mouth for 5 days starting seven 7 days prior to the DC vaccine cycle to reduce Treg activity. Low-dose cyclophosphamide will be taken every 14 days for six 6 cycles. A total of 6 vaccines containing 1 x 10\^7 TAPA-pulsed DC will be administered SQ every 14 days. The DC vaccine is given on Day 1 of the DCV cycle plus low-dose GM-CSF 50mcg/day SQ x 5 days (Day 1 to Day 4). GM-CSF is administered for 5 days to increase monocyte production and dendritic cell precursors to optimize immune responses.

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Kiromic BioPharma Inc.

INDUSTRY